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SUMMARY
C3H/HeN mice were immunized to induce contrasuppressor T-cell (Tcs) activity, splenic T cells from
these mice were fused with the BW5147 thymoma, and the resulting hybridomas were tested for their
ability to produce a contrasuppressor T-cell factor (TcsF). Nine TcsF-producing hybridomas were
preliminarily identified by their ability to inhibit the effect of antigen-specific suppressor T-cell factor
(TsF) on the adoptive transfer of contact sensitivity. One of these hybrids, AF5.C6, was cloned, the
production of a contrasuppressor factor confirmed, and the high-titred TcsF produced by this cloned
hybrid characterized. Hybridoma-derived TcsF is antigen-specific and specifically binds its antigen,
but does not bear immunoglobulin (Ig) determinants. Thus, hybridoma-derived TcsF is serologically
and functionally identical to an antigen-specific contrasuppressor factor for contact sensitivity,
whose production from splenocyte cell cultures has previously been described. The generation of a
hybridoma secreting a contrasuppressor factor identical to that produced by spleen cells significantly
strengthens the hypothesis that the phenomenon ofT-cell contrasuppression is mediated by a specific
subset of cells whose activity is contrasuppressive. The further advantages of employing T-cell
hybridomas for functional, biochemical and molecular genetic analyses ofcontrasuppression are also
discussed.
INTRODUCTION
Cell-mediated responses to contact sensitizing agents provide an
excellent model for studying the immune system in a physiologi-
cal, in vivo setting. Classic in vivo studies of delayed-type
hypersensitivity (DTH) have emphasized the importance of co-
operation between multiple cell types in generating an immune
response and the multiple layers of regulation imposed on the
response by both T lymphocytes and other cells (Youdim,
Stutman & Good, 1973; Vadas et al., 1976; Ptak et al., 1982;
Asherson, Colizzi & Zembala, 1986). The layers of T-cell
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TNCB, trinitrochlorobenzene; TNP, trinitrophenyl; Ts, suppressor T
cell; TsF, suppressor T-cell factor.
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regulation which have been investigated include both suppres-
sor T cells (Ts), which inhibit the activity of inducer or effector
cells, and contrasuppressor T cells (Tcs), which have effects
opposed to suppressor T cells (Gershon et al., 1981; reviewed by
Green, Flood & Gershon, 1983; Dorf & Benacerraf, 1984;
Green & Gershon, 1984).
Although the net effect of contrasuppressor activity is often
to increase the quantity ofan immune response, contrasuppres-
sive activity is distinct from that ofhelper-inducer cells (Green&
Gershon, 1984). Contrasuppressor cells can be distinguished
from helper-inducer cells by several criteria. First, contrasup-
pressor cells usually bear different patterns of cell-surface
antigens than helper-inducer cells. Second, the action ofcontra-
suppressor cells is unlike that of helper-inducer cells. Helper
cells act directly via secreted lymphokines to promote the
growth and eventual differentiation of immunological effector
cells (Killar et al., 1987; Tony & Parker, 1985). In contrast,
studies in at least one human and one murine system show that
contrasuppressor cells act on helper-inducer cells to allow them
to continue their helper function, even in the presence of
suppressor T cells which would normally inhibit the helper-
inducer population (Green et al., 1981; Lehner & Brines, 1988).
Thus contrasuppressor cells have a potentially important role in




Both Ts and Tcs that control the adoptive transfer of the
contact sensitivity response to the trinitrophenyl (TNP) hapten
have been described (Zembala & Asherson, 1973; Ptak,
Rozycka & Rewicka, 1979; Ptak et al., 1984a, b; Rosenstein et
al., 1981). In this system, the adoptive transfer of splenic T cells
from animal skin painted with picryl chloride (TNCB, a lipid
soluble form ofTNP which contact sensitizes painted animals to
the TNP hapten) into naive recipient animals transfers contact
hypersensitivity. Pretreatment of the transfer population with
antigen-specific Ts cells or factors (Ptak et al., 1979, 1982;
Asherson & Zembala, 1981), or transfer of immune cells into
animals already tolerant to TNP (Ptak et al., 1984a, b), prevents
the transfer of CS. However, preincubation of TNCB-primed
cells with contrasuppressor T cells or factors prevents the
suppressive effect ofa subsequent exposure to suppressor T cells
(Ptak et al., 1984a, b). This contrasuppressor factor can be
detected in the conditioned media from cultures of spleen cells
from appropriately immunized mice.
While biochemical and functional studies of suppressor T-
cell factors (TsF) have progressed (Rosenstein et al., 1981;
Turck, Kapp & Webb, 1985; Miller & Jenkins, 1986), no
contrasuppressor T-cell factor (TcsF) from any experimental
system has been extensively studied. In order to examine TcsF in
greater detail, a monoclonal source of a TcsF was required.
Animals were immunized using two separate protocols known
to induce antigen-specific contrasuppressor T cells which are
active in the adoptive transfer of contact sensitivity to TNP.
Somatic cell hybridization techniques were then used to gener-
ate T-cell hybridomas producing TcsF. Here we report the
production of a T-cell hybridoma secreting a factor which is




CBA/J (H-2k) male mice were purchased from Jackson Labs
(Bar Harbor, ME) and used between 7 and 16 weeks of age.
Cell lines
1591-RE is an ultraviolet light-induced (UV) sarcoma of C3H/
HeN mice (vanWaes et al., 1986). It regresses after injection into
normal syngeneic mice, but grows progressively in immunocom-
promised mice. 1591-RE was maintained in vitro in DMEM
with 10% foetal calf serum (FCS). BW5 147, an azaguanine-
resistant (HGPRT) variant of the AKR/J lymphoma (Goldsby
et al., 1977), was the kind gift ofDr N. Ruddle, Yale University.
The T-cell hybridomas produced in this study and the parental
BW5147 line were maintained in vitro by serial passage in
DMEM with 10% FCS.
Reagents and antibodies
Trinitrochlorobenzene (TNCB; Chemtronix, Swannanoa, NC),
sodium trinitrobenzenesulphonate (TNBS; Eastman Kodak,
Rochester, NY) and 4-ethoxymethylene-2-phenyloxazolone
(OX; Gallard Schlesinger, Carle Place, NY) were purchased
from the indicated suppliers. All reagents were used as received
except TNCB, which was twice recrystallized from hot methanol
before use. A goat antiserum to the murine immunoglobulin
determinants expressed on a mixture of murine myeloma
proteins (anti-MMP) was a kind gift of Dr G. M. Iverson, Yale
University. Anti-I-Jk antibody (B1OA.3R anti-BlOA.5R sera,
ASM 18) and antiIJb antibody (BlOA.5R anti-BIOA.3R sera,
ASM 19) were kind gifts from Dr D. Murphy, Yale University.
The specificity ofthese exact antisera for allelic I-J determinants
and their activity against appropriate regulatory factors have
been described previously by Flood et al. (1986). Mouse
immunoglobulin G (mIgG) was purified from normal CBA/J
mouse serum by ammonium sulphate precipitation followed by
gel filtration. The IgG fraction was then labelled with TNP, as
described by Rittenberg & Amkraut (1966). The resulting
substitution ratio for TNP-mIgG, determined spectrophotome-
trically, was 20 TNP residues per IgG molecule. The N-acetyl-D-
galactosamine binding lectin from the Vicia villosa plant was
purified by the method of Tollefsen & Kornfeld (1983).
Recombinant lymphokines were obtained from Hoffman-
LaRoche, Nutley, NJ (rIL-1 and rIL-2), and Amgene, Thou-
sand Oaks, CA (rIL-4). Units of lymphokine activity were
defined as the amount of lymphokine needed to induce 50%
optimal proliferation of the indicator cell lines D10 and HT-2
(Kaye et al., 1984; Kupper et al., 1987a).
Hapten modification of cells
1591-RE cells (107/ml) were modified withTNP by incubation in
1 mM TNBS in phosphate-buffered saline (PBS) for 5- 10 min at
room temperature. The reaction was stopped by the addition of
PBS with 10% FCS followed by extensive washing in PBS.
Viability of cells after treatment was greater than 95%, as
measured by trypan blue dye exclusion.
Adoptive transfer ofcontact sensitivity; assayfor contrasuppres-
sive activity
Contrasuppressive activity of splenic and hybridoma-derived
contrasuppressor factors was assayed by the adoptive transfer
ofcontact sensitivity, which was performed as described by Ptak
et al. (1984a, b). Briefly, donor mice were immunized for contact
sensitivity by percutaneous application of either TNCB or OX.
Four days later cell suspensions from spleens and lymph nodes
of immunized animals (hereinafter referred to as TNP- or OX-
immune cells) were prepared and incubated for 1 hr at 37°, with
the material being tested for contrasuppressive activity. Can-
tor's balanced salt solution (BSS) was used as a control medium
for incubations. After washing, cells were incubated with an
excess of the appropriate antigen-specific TsF (Asherson &
Zembala, 1981). Cells were washed prior to injection and then
6-6-5 x 107 cells were injected i.v. into naive, syngeneic reci-
pients. One ear of each recipient was challenged with the
appropriate antigen and triplicate measurements of ear thick-
ness were made 24 hr later by a second experimenter who did not
know the identity of the experimental groups.
Experimental groups consisted of four or five animals per
group. The increment in ear thickness is expressed as the mean
of the difference between challenged and unchallenged
ears+SD in units of 10-3 cm. In each experiment the non-
specific swelling in a control group of naive mice that did not
receive immune cells was determined and has been subtracted
from the values for the experimental groups. In Figs 1-3 and
Table 2 the results are also expressed as the percentage response,
with the positive control (response not modified by any
regulatory factors) group considered as a 100% response.
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Preparation of TsF and TcsF
TsF and TcsF from splenic sources were prepared as described
by Ptak et al. (1984a, b). Culture supernatants of hybridoma
lines and clones were used as a source of hybridoma-derived
TcsF. Cultures were initiated in DMEM with 10% FCS at
2 5 x 104 hybrid cells per ml. After 4 days supernatants were
harvested by centrifugation.
Affinity chromatography
Affinity matrices were prepared and affinity chromatography
performed as described by Ptak et al. (1984a, b).
RESULTS
Generation of contrasuppressor T cell hybridomas
Mice were immunized by either of two protocols, which
previous studies have shown lead to the generation offunctional
Tcs for the contact sensitivity response to TNP. Some mice
received an i.v. injection of 200 yl of 1 mg/ml TNP-coupled
mIgG (Ptak et al., 1984a, b), while others received an s.c.
injection of 107 TNP-coupled 1591 -RE tumour cells (Flood et al,
1988a, b). Spleens were removed 8 days after immunization and
cell suspensions were depleted of sIg+ cells by the method of
Wigzell (1976). Cell suspensions were further purified by
adherence to plastic plates coated with the Vicia villosa lectin, as
described by Green et al. (1981). Adherence to the V. villosa
lectin was used because it is a general property of Tcs cells, but
not ofT helper (Th), T inflammatory (Tinf), or Ts cells (Green et
al., 1981; Ptak et al., 1984a., b). Lectin-adherent cells were then
fused to the AKR T-cell lymphoma BW5147 with polyethylene
glycol (PEG) 1540, as described by Beezley & Ruddle (1982).
Fused cells were seeded in HAT media at the equivalent of
3 x I04 BW5147 cells per well. After 14 days ofselection, 13/360
wells were positive for growth. Positive wells were expanded,
and supernatants from 19 of them were screened for contrasup-
pressive activity. Lines were assayed over a period of 4-8 weeks
following fusion.
The screening assay tested the ability of supernatant from
these lines to inhibit the suppressive effects of the TNP-specific
T-cell suppressor factor (TNP-TsF) on the adoptive transfer of
contact sensitivity. Nine of the lines showed significant activity
in the screening assay (Table 1). They were AF5 from TNP-
1591-RE-immunized animals, and ECl 1, EF8, FB5, FC2, FE7,
FF5, FF6 and FF7 from mice immunized with TNP-mIgG.
These lines were cloned by limiting dilution inDMEM with 10%
FCS and 25% media conditioned by growth of BW5147.
Limiting dilution clones which produce a putative contrasup-
pressive activity were obtained from all of the lines. One of these
clones, AF5.C6, was randomly selected for further study. The
AF5.C6 cell line was analysed for the expression of cell-surface
antigens by immunofluorescent staining and flow cytometry. It
bore allelic determinants of the Thy-l and CD5 antigens
appropriate to both BW5147 and CBA/J parental cells, as well
as CD3 and CD4 antigens. No CD8 or sIg determinants could
be detected (data not shown). The pattern of cell-surface
antigens detected on the AF5.C6 hybridoma was consistent with
that expressed by the cells required for the production ofTNP-
specific TcsF from cultures of splenocytes, namely CD5 +,
CD8-, I-J+ and Thy-l+ (Ptak et al., 1984a).
Table 1. Screening hybridoma lines for contrasuppressive activity
% inhibition ofTNP-TsF-
Hybridoma cell line mediated suppression





















Supernatants from hybrid cell lines surviving HAT selection were
screened for contrasuppressive activity by their ability to inhibit the
effect of a subsequent incubation with an antigen-specific suppressor T-
cell factor in the adoptive transfer of contact sensitivity. This table
summarizes several screening experiments. Cells from TNP-sensitized
donors were first incubated with 15 ml of tissue culture supernatants of
the hybrid cell lines for 1 hr at 37°, then washed and incubated with 5 ml
of the TNP-specific suppressor factor, TNP-TsF, for 1 hr at 37°. Each
experiment included cells treated with BSS for both incubations, the
positive control, and cells suppressed by treatment with BSS for the first
incubation and TNP-TsF for the second. Cells were then washed and
transferred to naive recipients and the remainder of the assay per-
formed, as described in the Materials and Methods. In order to compare
results from independent experiments, the percentage inhibition of the
extent of suppression obtained in each experiment was determined.
Percentage inhibition of suppression =(experimental response with
indicated hybridoma supernatant -suppressed response in the absence
of hybridoma supernatant) (positive control response - suppressed
response) x 100.
Hybridoma-produced factor is functionally identical to that of
previously reported contrasuppressor factor
We examined whether the AF5.C6 hybridoma produced a
supernatant factor with properties similar to those of the TcsF
previously identified in cultures of spleen cells from appropri-
ately immunized animals. In these studies the spleen cell-derived
TcsF from animals immunized with either TNP-mlg or TNP-
1591-RE tumour cells served as the standard of comparison for
TcsF activity. In the first experiment, the effects of the various
TcsFs on the adoptive transfer of contact sensitivity were
compared directly. PCl-immune cells were incubated with 48-hr
supernatant collected from the AF5.C6 hybridoma, super-
natant from 48-hr cultures of splenocytes from animals immu-
nized with TNP-mIg (TNP-mIg-TcsF) or TNP- 1 591-RE (TNP-
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Figure 1. (a) AF5.C6 supernatant functions equivalently to contrasup-
pressor factor derived from splenocyte cultures. TNP-immune cells were
first incubated 1 hr at 370 with 15 ml of either BSS, contrasuppressor
factor from various splenic or hybridoma sources, or BW5147 super-
natant as a fusion partner control. Cells were then washed and
incubated with 5 ml of BSS or TNP-TsF for 1 hr at 37°. The assay was
then completed as described in the Materials and Methods. TNP-mIgG
TcsF was a supernatant from cultured spleen cells of mice immunized
with TNP-mIgG (Ptak et al., 1984a); TNP-1591-RE TcsF was similarly
derived from mice immunized with TNP-modified 1591-RE UV
regressor tumour cells. (b) AF5.C6 supernatant possesses contrasup-
pressive but not helper activity. TNP-immune cells were incubated in 20
ml of BSS or AF5.C6 supernatant for 1 hr at 37°, washed and then
incubated in 7 ml of BSS or TNP-TsF for 1 hr at 37°. Assay was
completed as described.
AF5.C6. These TNCB immune cells were then washed, and
incubated with TNP-TsF prior to transfer into naive recipients.
The results in Fig. 1 indicate that incubation of TNCB-
immune cells with TNP-TsF prior to transfer into naive
recipients suppresses their ability to adoptively transfer contact
sensitivity (Fig. la, lines 1 and 2). Supernatant from the AF5.C6
hybridoma functions equivalently to supernatants of splenocyte
cultures from mice immunized with TNP- 1591-RE (TNP- 1591-
RE TcsF) or TNP-mIgG (TNP-mIgG TcsF), in that all three
sources of factor inhibited the activity of TNP-TsF (Fig. la,
lines 3, 4 and 5). An equivalent supernatant from the BW5147
fusion partner had no activity in this assay (line 6).
Since the unique biological activity of Tcs factors is to
enhance immunological responses inhibited by Ts, it was
important to determine whether AF5.C6 TcsF enhanced con-
tact sensitivity responses both in the presence and absence of
suppression. Therefore, in Fig. b, the activity of AF5.C6
supernatants was analysed with and without subsequent treat-
ment with the antigen-specific suppressor factor, TNP-TsF.
Factor from the AF5.C6 hybridoma fully inhibited the suppres-
sion mediated by TNP-TsF, but did not affect an adoptive
transfer in the absence of TNP-TsF: the response of a group
treated with AF5.C6 supernatant and then a balanced salt
solution (BSS) control was no different from the positive control
group that was treated with BSS only. No enhancement of the
transfer of contact sensitivity was seen, even when suboptimal
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Dilution of AF5.C6 supernatant followed by
a constant amount of TNP-TsF
Figure 2. AF5.C6 contrasuppressor factor is antigen-specific. Cells from
mice immunized with TNCB (TNP contact sensitivity) or OX (OX
contact sensitivity) were incubated in 10 ml of BSS or AF5.C6
supernatant for 1 hr at 370, washed and then incubated in 10 ml of BSS
or the appropriate antigen-specific T suppressor factor (TNP-TsF or
OX-TsF) for 1 hr at 37°. After washing, cells were transferred to naive
recipients, which were immediately challenged with the matching hapten
on the ear. Ear swelling was measured 24 hr later.
derived TcsF was not functioning by enhancing the immune
activity of a small number of cells not affected by antigen-
specific TsF (data not shown). The same ability to alter
suppressed responses without affecting unsuppressed ones was
shown by TcsF from spleen cell culture supernatants, and this is
consistent with the positive immunoregulatory activity in the
hybridoma-produced factor being a contrasuppressive activity.
In order to further investigate the contrasuppressive activity
of AF5.C6-derived TcsF, we titrated this factor versus a
constant number ofimmune transfer cells and a constant dose of
TNP-TsF (Fig. 2). Three dilutions of supernatant, 1:1, 1:10,
and 1:100, were active in contrasuppressing the adoptive
response. Moreover, the responses seen in these groups were not
significantly different from each other or from the unsuppressed
positive control group. Contrasuppressor factor, even 100-fold
in excess of that required for complete restoration of a positive
control response, therefore, does not augment a response above
that seen in the absence of suppression. In contrast, dilutions of
supernatant of 1:1000 and greater were ineffective and gave a
response no different from the suppressed group. Further
titration experiments (data not shown) revealed that dilutions of
AF5.C6 contrasuppressor factor between 1: 100 and 1: 1000
exerted partial contrasuppressive effects on the adoptive
transfer response. The partial response in this range suggests
that contrasuppression is not an 'all-or-none' phenomenon.
The contrasuppressive activity from AF5.C6 is antigen-specific
The splenic contrasuppressor cells and factors produced by
immunization with TNP-1591-RE tumour cells or TNP-mIgG
are specific for the TNP hapten (Ptak et al., 1984; Flood et al.,
1988a, b). We tested the antigen-specificity of the AF5.C6
hybridoma-derived factor using OX, a potent contact-sensitiz-
ing hapten that is not cross-reactive with TNP (Fig. 3). TNP or
OX immune cells were treated with AF5.C6-derived super-
natant, washed, then incubated with their homologous TsF.
While the AF5.C6 hybridoma-derived factor could inhibit the
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Figure 3. Titration ofAF5.C6 TcsF. TNP-immune cells were incubated
with 5 ml of either BSS, AF5.C6 supernatant or serial 1: 10 dilutions of
AF5.C6 supernatant in BSS for 1 hr at 37°. Cells were then washed and
incubated in 5 ml of either BSS or undiluted TNP-TsF for 1 hr at 37°.
The positive (+ ve) control group was incubated in 5 ml of BSS for both
the first and second incubation, while the TsF only group received 5 ml
of BSS for the first incubation and then 5 ml of undiluted TNP-TsF for
the second. The assay was completed as above.
suppression of the adoptive transfer of TNP-specific contact
sensitivity mediated by TNP-TsF on PCl-immune cells, an equal
amount of AF5.C6 supernatant was unable to inhibit the
suppression of the adoptive transfer of OX-specific contact
sensitivity mediated by the analogous OX-specific suppressor
factor (OX-TsF) on OX-immune cells.
Serological analysis of TcsF from AF5.C6 indicates that it
binds to native antigen in the absence of major histocompatibi-
lity complex (MHC) gene products. We fractionated AF5.C6
TcsF via affinity chromatography on Sepharose 4B columns
substituted with bovine gamma globulin modified with TNP
(TNP-BGG) or OX (OX-BGG). AF5.C6 TcsF was passed over
TNP-BGG or OX-BGG columns, and both filtrate and eluate
were assayed for their ability to reverse the suppressive effects of
TNP-TsF on TNP-immune cells in adoptive transfer. The
results, in Table 2, Exp. 1, indicate that the contrasuppressive
activity bound to and could be eluted from the TNP-BGG
column, but had no affinity for OX-BGG. Therefore, it appears
as though the TNP-specific TcsF from AF5.C6 binds to TNP
but not to OX or to BGG.
Similar affinity chromatography analyses were done to
detect the presence of I-J or immunoglobulin serological
determinants on AF5.C6 TcsF. In Table 2, Exp. 2, AF5.C6-
produced TcsF was analysed for binding to a goat antiserum
directed against a mixture of mouse myeloma proteins (anti-
MMP). This goat antiserum reacts with immunoglobulin heavy
chains of the u, y and a classes and light chains of the K and A
classes. Contrasuppressive activity was found in the unbound
filtrate fraction, suggesting that the factor does not bear
determinants associated with immunoglobulin molecules. In
Exps 3 and 4, anti-I-J alloantisera were employed to detect any
allelic determinants of I-J expressed on the active factor. The
results in Exps 3 and 4 suggest that the AF5.C6 TcsF bears I Jk
but not IJb determinants, matching the MHC haplotype of the
CBA/J source of the hybrid. These experiments show that
AF5.C6-derived TcsF is antigen-binding, Ig-, I-Jk+, and I-Jb-.
This affinity profile is identical to that of factor produced from
splenocytes immunized with TNP- 1591-RE or TNP-mIgG
Table 2. Affinity column analysis of TcsF in AF5.C6 supernatants
First Second Response % of +ve
incubation incubation (10-2 mm+ SD) control
Exp. 1, TNP-BGG and OX-BGG
BSS BSS 13-1+ 19 +ve
BSS TNP-TsF 1 5+0 7 11
TNP eluate TNP-TsF 12 2+1-4 93
TNP filtrate TNP-TsF 3-3 +0 5 25
OX eluate TNP-TsF 3-6+±05 27
OX filtrate TNP-TsF 11 2+1 6 86
Exp. 2, goat antiserum to mixed MMP
BSS BSS 91+009 + ve
BSS TNP-TsF 2-3+0 8 25
a-MMP eluate TNP-TsF 1-8+0 3 20
a-MMP filtrate TNP-TsF 8-6 +0 8 95
Exp. 3, ASM-19, an anti-I-Jk alloantiserum
BSS BSS 9 1+09 +ve
BSS TNP-TsF 2 3+0-8 25
MI-Jk eluate TNP-TsF 93 +0 6 102
otI-Jk filtrate TNP-TsF 1 9+1 1 21
Exp. 4, ASM-20, an anti-IlJb alloantiserum
BSS BSS 105+17 +ve
BSS TNP-TsF 2 4+003 23
otI-Jb eluate TNP-TsF 2 8 +0 6 27
x-I-Jb filtrate TNP-TsF 9 1+0 3 87
Ten ml of AF5.C6 supernatants were fractionated on affinity
columns containing the indicated adsorbent coupled to Sepharose
4B. Affinity adsorbents were prepared and fractionation was
performed according to the method of Ptak et al. (1984a). The
unbound filtrate fraction was collected by washing with 0-3 M
sodium borate, pH 8 6, and the eluate fraction was formed by
elution with 0-2 M sodium carbonate, pH 11. After the filtrate and
eluate fractions were reconcentrated to the original 10 ml volume
and extensively dialysed versus BSS, they were tested for contrasup-
pressive activity as described above.
(Ptak et al., 1984a, b; Flood et al., 1988a, b). The identity of the
serological properties between hybridoma and whole spleen-
derived TcsF further reinforces the evidence for the equivalence
of factor from these two sources.
The contrasuppressive activity in AF5.C6 hybridoma-derived
factor is not due to previously defined lymphokines
The antigen specificity and affinity for nominal antigen dis-
tinguishes the AF5.C6-derived TcsF from previously described
lymphokines. Nonetheless, we sought to formally demonstrate
that contrasuppressive activity was not due to T cell-derived
lymphokines. Therefore, we asked whether supernatants from
activated Th or Tinf cells (Mosmann et al., 1986), or genetically
engineered recombinant lymphokines, could substitute for
AF5.C6-TcsF and overcome the suppressive effects ofTNP-TsF
on PCl-immune cells. The results in Fig. 4 indicate that 24-hr
supernatants from Con A activated CI0 (Tinf cell whose
supernatant contains IL-2, IL-3 and GM-CSF activity) or D1O
(Th cell whose supernatant contains IL-3, IL-4, IL-5 and GM-
CSF activity) (Horowitz & Murphy, 1983; Kupper, Horowitz &
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Figure 4. CD4+ T-cell supernatant or recombinant lymphokines do not
substitute for AF5.C6 TcsF. TNP-immune cells were incubated with 5
ml of either BSS, neat AF5.C6 supernatant, supernatant from cloned
C 10 or D 0 T-cell lines activated for 24 hr with 1 5 pg/ml of Conc A, or
with the indicated dose of recombinant lymphokines diluted in BSS for 1
hr at 37°. Cells were then washed and incubated in 5 ml of either BSS or
undiluted TNP-TsF for 1 hr at 37°. The positive (+ve) control group
was incubated in 5 ml of BSS for both the first and second incubation,
while the TsF only group received 5 ml of BSS for the first incubation
and then 5 ml of undiluted TNP-TsF for the second. The assay was
completed as above.
reverse the suppressive effects of TNP-TsF on TNP-immune
cells. Conversely, TNP affinity-purified AF5.C6-F completely
reversed the suppressive effects of TNP-TsF and restored the
ability of PCl-immune cells to transfer CS to TNP. Further-
more, analysis of the TNP affinity-purified supernatant from the
AF5.C6 hybridoma could not detect IL-I, IL-2, IL-3, IL-4 or
GM-CSF using the indicator cell lines D 0 (for IL- 1; Kaye et al.,
1984), HT-2 (for IL-2, IL-4 and GM-CSF; Kupper et al., 1987b)
and MC-9 (for IL-3; Kupper et al., 1989). Therefore, we
conclude that the activity in AF5.C6-F capable of reversing
TNP-TsF-mediated suppression is not due to the activity of IL-
1, IL-2, IL-3, IL-4 or GM-CSF, either alone or in combination
with other as yet undescribed lymphokines.
DISCUSSION
We describe here the generation of a T-cell hybridoma secreting
an antigen-specific factor which protects TNP-immune cells
from the suppressive activity ofa TNP-specific suppressor T-cell
factor in an adoptive transfer system. We have defined this
activity as 'contrasuppression' (Ptak et al., 1984a, b), and this
hybridoma appears to be a faithful representative of spleen cell-
derived TcsF for the following reasons. First, AF5.C6 TcsF
duplicates the contrasuppressive activity of TcsF from splenic
sources; second, TcsF, from both AF5.C6 and spleen cell
supernatants, inhibits the activity of antigen-specific TsF in the
adoptive transfer of contact sensitivity without augmenting the
adoptive transfer in the absence of TsF; third, TcsF of both
splenic and hybridoma origin is antigen-specific and binds that
antigen specifically; fourth, factor from both sources exhibits
identical serological profiles; in addition to binding to their
specific antigen, both splenic and AF5.C6 TcsF express determi-
nants linked to the I-J locus, but not conventional immuno-
globulin determinants; and, finally, TcsF from both splenic and
hybridoma sources function by inducing release of an antigen
non-specific intermediary contrasuppressor factor (A. M. Fried-
man et al., manuscript in preparation). Thus, in all respects so
far investigated, the monoclonal hybridoma-derived factor is
functionally and serologically identical to the spleen cell-derived
contrasuppressor factor of Ptak et al. (1984a, b). Thus our
evidence indicates that the AF5.C6 hybridoma can reasonably
be used as a model for the splenic activity of contrasuppression.
Therefore, the AF5.C6 hybridoma provides us with a long-
term, homogeneous source of contrasuppressor cells to study
the functional, biochemical and molecular genetic basis of
contrasuppression. Using this hybridoma, we have found that,
first, none of the T-cell lymphokines tested is responsible for
contrasuppressive activity. The fact that this factor is specific for
the TNP hapten distinguishes it from the non-specific lympho-
kines IL-1, IL-2, IL-3, IL-4 and GM-CSF. Our results also
indicate that the contrasuppressive effect of AF5.C6 factor is
not due to lymphokines. The antigen-specific effect of TcsF on
the adoptive transfer ofcontact sensitivity can not be duplicated
by recombinant IL-1, IL-2 or IL-4 or any combination of these
lymphokines produced by T-cell clones after stimulation.
Furthermore, affinity column fractions of hybridoma super-
natant, which are active in the adoptive transfer system, do not
exhibit any lymphokine activity on appropriate indicator cell
lines. Second, we could detect neither lymphokine secretion
from nor growth inhibition of the AF5.C6 hybridoma following
incubation with CBA/J feeder cells and either cell-bound or
soluble TNP, as has been reported for other hybridomas
(Kappler et al., 1981; Ashwell et al., 1987). This indicates that
this hybridoma does not behave in the same fashion as antigen-
specific helper hybridomas.
Perhaps the most important result flowing from the genera-
tion of a contrasuppressor hybridoma is the support it provides
to the hypothesis that contrasuppression is a distinct regulatory
phenomenon mediated by a distinct class of cells (or by cells in a
distinct state of differentiation). Alternative models would
suggest that contrasuppression is either a phenomenon
mediated by cells which also perform other functions or results
from interactions within the immune system as a whole with no
particular class of cells being contrasuppressive. Our demon-
stration that it is possible to develop a cell line whose activity is
distinctly contrasuppressive, and seemingly without any other
activities, suggests that contrasuppression is indeed mediated by
cells whose function is specifically contrasuppressive. Our
ability to immortalize a limited number of cells by somatic cell
hybridization and have their hybrid progeny mediate contra-
suppressive function suggests that contrasuppression resides
with individual or small numbers of cells and not within the
system as a whole. Definitive proof of this hypothesis, however,
still awaits the culturing oflong-term, non-transformed cell lines
and clones with contrasuppressive activity.
The techniques that we describe for the generation of this
hybridoma should be generally applicable to the production of
hybridomas-secreting factors mediating other forms of contra-
suppressive activity. These other forms of contrasuppressive
activity have also only been identified in primary cultures of
lymphoid cells. Applying these techniques to the development of
hybridomas from various cells with contrasuppressive activity
should increase the precision with which the entire field of
contrasuppression is studied. Hybridomas secreting contrasup-
pressive factors from various systems should help clarify both
the relationship between contrasuppressor cells identified in
disparate systems, and the relationship between contrasuppres-
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Although they are both antigen-specific molecules, AF5.C6-
derived TcsF does not appear to be related to B cell-derived
antibody. AF5.C6 TcsF does not bind to anti-immunoglobulin
reagents, but is bound by specific anti-I-J antibodies. This
serological evidence combined with previous data showing the
production of TcsF from T-cell, but not B-cell, fractions of
splenocytes, distinguish this factor from immunoglobulin.
While the existence of a hybridoma-secreting monoclonal
contrasuppressor factor provides the best evidence yet for the
existance of contrasuppression as a distinct regulatory pheno-
menon, it has also helped increase our insight into the functional
aspects of contrasuppression. While the activity of TNP-
immune cells is normally reduced by TNP-TsF, when contra-
suppressor factor is incubated with the cells before TNP-TsF
treatment the activity ofTNP-immune cells is preserved. Three
possible mechanisms could account for these results: (i) TcsF
works directly on immune cells to enhance their activity, but this
enhancement is decreased by TsF leaving the treated cells with
the same net activity as untreated cells; (ii) TcsF uses TsF as a
co-factor to enhance the activity of immune cells; or (iii) TcsF
protects cells from the action of TsF without enhancing their
activity. The protection of cells by TcsF could be mediated by
any of several mechanisms.
Our results indicate that the first alternative is not viable. We
have shown that hybridoma-derived factor does not augment a
response in the absence of TNP-TsF, even if 100-fold excess
hybridoma-derived TcsF is used. In addition, treatment and
transfer of suboptimal numbers of cells in the absence of TsF
suppression does not augment the CS response seen. Therefore,
AF5.C6 TcsF does not contrasuppress by enhancing the activity
of limiting numbers of cells. These data suggest that TcsF does
not increase the biological activity of TNP-immune cells, and
under the experimental conditions employed here does not
function as a helper factor like the one described by Collizi et al.
(1984).
The second possible mechanism is that TcsF may use TsF as
a co-factor to directly enhance the activity of PCl-immune cells.
However, recent results show that TcsF has a contrasuppressive
activity even in the absence ofTsF. The TNP-specific TcsF from
AF5.C6 induces an antigen non-specific intermediary contra-
suppressor factor from TNP-immune cells even in the complete
absence ofTsF. This antigen non-specific TcsF also protects the
adoptive transfer of contact sensitivity. Thus, AF5.C6 TcsF
does not directly require a co-factor from TsF to augment
contact sensitivity.
Using this hybrid we can begin to explore the relationship
between TcsF and other antigen-recognizing structures on T
lymphocytes, including suppressor T-cell factors, and the
heterodimeric a:P and y: 5 structures found on helper and
cytolytic T cells (Haskins, Kappler & Marrack, 1984; Brenner et
al., 1986). In addition, a monoclonal source of TcsF will allow
ever more precise investigation of the role of contrasuppression
in the control of contact sensitivity and other cell-mediated
responses. Preliminary evidence suggests that AF5.C6 TcsF can
turn tolerogenic doses ofTNP into immunogenic ones, activate
TNP-specific CTL in vivo, and induce potent anti-tumour
immune responses capable of rejecting a challenge of TNP-
haptenated metastatic tumour cells. The AF5.C6 hybridoma
and its secreted product should serve as a useful, well-defined
and relevant tool for further investigations of both the cellular
and molecular nature of T-cell contrasuppression.
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